ADVERTISEMENT
Search

 

Press Releases

 

22

Dec

2021

FDA’s Decision to Block Pharmacists from Ordering COVID-19 Oral Antivirals Will Hurt COVID Positive Patients, National Pharmacy Groups Warn

The American Pharmacists Association (APhA), American Society of Consultant Pharmacists (ASCP), American Society of Health System Pharmacists (ASHP), National Alliance of State Pharmacy Associations (NASPA), and the National Community Pharmacists Association (NCPA) today issued the following statement in response to the FDA’s decision to authorize the Pfizer COVID-19 oral antiviral but specifically prevent pharmacists from writing the prescriptions:

Comments (0)
Number of views (9232)
Article rating: 5.0

30

Nov

2021

Pharmacy Groups: CMS Guidance Sets Up Oral Antivirals for Failure, Limiting Patients’ Access to COVID-19 Treatments

A group of six pharmacy organizations today criticized the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to only “encourage” but not require payment to pharmacists for testing, patient assessment, ordering/prescribing and dispensing for oral COVID-19 antiviral drugs

Comments (0)
Number of views (6258)
Article rating: 4.7

3

Nov

2021

Pharmacies prepare to make COVID vaccines available to their communities

The American Pharmacists Association is committed to working with pharmacy teams, public health and other stakeholders following the decision of the Centers for Disease Control and Prevention (CDC)  to recommend that children age 5 to 11 be vaccinated against COVID-19.

Comments (0)
Number of views (2356)
Article rating: No rating

20

Oct

2021

APhA Statement on Administration Plan to Vaccinate Children Age 5 to 11 Against COVID-19

The American Pharmacists Association supports the Biden administration’s efforts to implement a comprehensive plan to vaccinate children age 5 to 11 against COVID-19.

Comments (0)
Number of views (2780)
Article rating: 4.0

1

Sep

2021

AMA, APhA, ASHP Call for Immediate End to Prescribing, Dispensing, and Use of Ivermectin to Prevent or Treat COVID-19 Outside Clinical Trials

WASHINGTON, DC –  The American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) strongly oppose the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.

Comments (0)
Number of views (11465)
Article rating: 2.3
RSS
123